OlopatadineThird Party Manufacturing in India

Olopatadine works by utilizing a dual-action pathway to address ocular allergy symptoms. It acts as a selective histamine H1-receptor antagonist to block circulating histamines from binding to conjunctival cells, rapidly reducing itching and redness. Concurrently, it stabilizes mast cell membranes to prevent the release of inflammatory mediators like interleukins and leukotrienes. Unlike simple oral antihistamines, it targets the ocular surface directly to provide relief without causing systemic drowsiness. It is highly effective and well-tolerated.

Therapeutic Uses

• Seasonal Allergic Conjunctivitis: Prevents and treats acute eye itching and redness caused by airborne pollen or environmental allergens.
• Giant Papillary Conjunctivitis: Reduces contact lens-induced mechanical inflammation and associated mucous discharge.
• Perennial Allergic Keratitis: Manages year-round ocular allergy symptoms triggered by dust mites or indoor mold.

Why Manufacturers Choose Olopatadine

Olopatadine is widely considered the clinical benchmark for topical ocular allergy treatments due to its rapid onset and long-lasting action. Procuring Olopatadine third party manufacturing in India allows companies to expand into the profitable consumer eye care and allergy markets. Our partner facilities are WHO-GMP certified, utilizing specialized formulation controls to ensure pH compatibility and minimize stinging upon application of the CAS 113806-05-6 compound.